Sign in

CIK 0001061983 · Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
943291317
Phone
(650) 624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Planned sale Director sold 5,000 shares at an average $54.73 ($273,635)
  2. 4 Planned sale EVP Research & Development sold 3,500 shares at $62.93 ($220,255)
  3. 4 Planned sale President & CEO sold 7,500 shares at $62.81 ($471,075)
  4. 4 Grant or award Director acquired 97 shares (grant or award)
  5. 4 Grant or award Director acquired 195 shares (grant or award)
  6. 4 Grant or award Director acquired 195 shares (grant or award)
  7. 4 Grant or award Director acquired 195 shares (grant or award)
  8. 4 Grant or award Director acquired 97 shares (grant or award)
  9. 4 Grant or award Director acquired 352 shares (grant or award)
  10. 4 Planned sale EVP Research & Development sold 3,500 shares at $64.01 ($224,035)
  11. 4 Planned sale President & CEO sold 7,500 shares at $62.88 ($471,600)
  12. 4 Planned sale EVP Research & Development sold 3,500 shares at $61.38 ($214,830)
  13. 4 Planned sale President & CEO sold 7,500 shares at $65.46 ($490,950)
  14. 4 Planned sale EVP Research & Development sold 3,500 shares at $68.29 ($239,015)
  15. 4 Planned sale Director sold 1,000 shares at $72.13 ($72,130)
  16. 4 Planned sale President & CEO sold 105,426 shares at an average $69.62 ($7,340,010)
  17. 4 Planned sale Director sold 1,000 shares at $74.66 ($74,660)
  18. 4 Planned sale EVP Research & Development sold 3,500 shares at $75.46 ($264,110)
  19. 4 Planned sale Director sold 5,000 shares at $71.48 ($357,400)
  20. 4 Planned sale EVP, Chief Commercial Officer sold 10,000 shares at $70.24 ($702,400)

Page 1 of 70 · 1,396 filings